Return On Equity of ROCKET PHARMACEUTICALS, INC. from 30 Sep 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
ROCKET PHARMACEUTICALS, INC. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2015 to 30 Sep 2025.
  • ROCKET PHARMACEUTICALS, INC. Return On Equity for the quarter ending 30 Sep 2025 was -62%, a 0.29% increase year-over-year.
  • ROCKET PHARMACEUTICALS, INC. annual Return On Equity for 2024 was -64%, a 23% decline from 2023.
  • ROCKET PHARMACEUTICALS, INC. annual Return On Equity for 2023 was -52%, a 2.9% increase from 2022.
  • ROCKET PHARMACEUTICALS, INC. annual Return On Equity for 2022 was -53%, a 51% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

ROCKET PHARMACEUTICALS, INC. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -62% +0.18% +0.29% 01 Jul 2025 30 Sep 2025
Q2 2025 -66% -12% -21% 01 Apr 2025 30 Jun 2025
Q1 2025 -65% -12% -22% 01 Jan 2025 31 Mar 2025
Q4 2024 -64% -12% -23% 01 Oct 2024 31 Dec 2024
Q3 2024 -63% -9.2% -17% 01 Jul 2024 30 Sep 2024
Q2 2024 -54% +3.4% +5.8% 01 Apr 2024 30 Jun 2024
Q1 2024 -53% +2.6% +4.7% 01 Jan 2024 31 Mar 2024
Q4 2023 -52% +1.6% +2.9% 01 Oct 2023 31 Dec 2023
Q3 2023 -53% -4.4% -9% 01 Jul 2023 30 Sep 2023
Q2 2023 -58% -14% -32% 01 Apr 2023 30 Jun 2023
Q1 2023 -56% -18% -50% 01 Jan 2023 31 Mar 2023
Q4 2022 -53% -18% -51% 01 Oct 2022 31 Dec 2022
Q3 2022 -49% -11% -29% 01 Jul 2022 30 Sep 2022
Q2 2022 -44% -5.5% -14% 01 Apr 2022 30 Jun 2022
Q1 2022 -37% +4.4% +11% 01 Jan 2022 31 Mar 2022
Q4 2021 -35% +7.6% +18% 01 Oct 2021 31 Dec 2021
Q3 2021 -38% -2.1% -5.9% 01 Jul 2021 30 Sep 2021
Q2 2021 -38% -5.9% -18% 01 Apr 2021 30 Jun 2021
Q1 2021 -42% -11% -35% 01 Jan 2021 31 Mar 2021
Q4 2020 -43% -11% -34% 01 Oct 2020 31 Dec 2020
Q3 2020 -36% +4% +10% 01 Jul 2020 30 Sep 2020
Q2 2020 -33% +10% +24% 01 Apr 2020 30 Jun 2020
Q1 2020 -31% +16% +34% 01 Jan 2020 31 Mar 2020
Q4 2019 -32% +13% +29% 01 Oct 2019 31 Dec 2019
Q3 2019 -40% +4.5% +10% 01 Jul 2019 30 Sep 2019
Q2 2019 -43% +2.4% +5.4% 01 Apr 2019 30 Jun 2019
Q1 2019 -47% -3% -6.8% 01 Jan 2019 31 Mar 2019
Q4 2018 -45% -3% -7.3% 01 Oct 2018 31 Dec 2018
Q3 2018 -44% -65% -313% 01 Jul 2018 30 Sep 2018
Q2 2018 -45% -54% -586% 01 Apr 2018 30 Jun 2018
Q1 2018 -44% -44% -14912% 01 Jan 2018 31 Mar 2018
Q4 2017 -42% -31% -298% 01 Oct 2017 31 Dec 2017
Q3 2017 21% +72% 01 Jul 2017 30 Sep 2017
Q2 2017 9.3% +111% 01 Apr 2017 30 Jun 2017
Q1 2017 -0.29% +116% +100% 01 Jan 2017 31 Mar 2017
Q4 2016 -11% +127% +92% 01 Oct 2016 31 Dec 2016
Q3 2016 -52% +138% +73% 01 Jul 2016 30 Sep 2016
Q2 2016 -101% 01 Apr 2016 30 Jun 2016
Q1 2016 -116% 01 Jan 2016 31 Mar 2016
Q4 2015 -138% 01 Oct 2015 31 Dec 2015
Q3 2015 -190% 01 Jul 2015 30 Sep 2015

ROCKET PHARMACEUTICALS, INC. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -64% -12% -23% 01 Jan 2024 31 Dec 2024
2023 -52% +1.6% +2.9% 01 Jan 2023 31 Dec 2023
2022 -53% -18% -51% 01 Jan 2022 31 Dec 2022
2021 -35% +7.6% +18% 01 Jan 2021 31 Dec 2021
2020 -43% -11% -34% 01 Jan 2020 31 Dec 2020
2019 -32% +13% +29% 01 Jan 2019 31 Dec 2019
2018 -45% -3% -7.3% 01 Jan 2018 31 Dec 2018
2017 -42% -31% -298% 01 Jan 2017 31 Dec 2017
2016 -11% +127% +92% 01 Jan 2016 31 Dec 2016
2015 -138% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.